#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	13756	16S	1529	1529	100.0	16S.l6.c30.ctg.1	2037	664.8	1	SNP	n	C1184T	0	.	.	1184	1184	C	1419	1419	C	757	C	745	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	13756	16S	1529	1529	100.0	16S.l6.c30.ctg.1	2037	664.8	0	HET	.	.	.	G395A	.	395	395	G	630	630	G	760	G,A	566,174	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25848	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3567	719.6	0	.	n	.	0	T695C	SNP	695	695	T	1073	1073	C	746	C,T	734,4	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25848	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3567	719.6	0	.	n	.	0	G1337A	SNP	1337	1337	G	1715	1715	A	799	A,G	783,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25848	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3567	719.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2349	2349	C	796	C	776	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25848	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3567	719.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2423	2423	A	857	A,G	851,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25848	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3567	719.6	1	SNP	n	C2597T	0	.	.	2597	2597	C	2975	2975	C	795	C,T	778,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	1900	folP	855	855	100.0	folP.l15.c4.ctg.1	1646	114.5	1	SNP	p	R229S	1	.	.	685	687	AGC	1031	1033	AGC	173;175;178	A;G;C	171;173;175	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5302	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3462	152.1	1	SNP	p	S91F	1	.	.	271	273	TTC	605	607	TTC	200;200;198	T;T,C;C	199;196,2;196	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5302	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3462	152.1	1	SNP	p	D95G	1	.	.	283	285	GGC	617	619	GGC	198;195;194	G;G,A;C	193;189,4;194	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5302	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3462	152.1	1	SNP	p	G95N	0	.	.	283	285	GGC	617	619	GGC	198;195;194	G;G,A;C	193;189,4;194	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	1762	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1535	114.4	1	SNP	p	G45D	0	.	.	133	135	GGC	608	610	GGC	221;223;222	G;G,A;C	213;212,3;212	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	858	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	878	96.0	0	.	n	.	0	A197.	DEL	197	197	A	553	553	A	168	A	166	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4656	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2991	154.4	1	SNP	p	D86N	0	.	.	256	258	GAC	690	692	GAC	196;196;200	G,A;A,G;C	193,1;188,1;195	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4656	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2991	154.4	1	SNP	p	R87W	0	.	.	259	261	CGT	693	695	CGT	201;194;194	C,A;G,A,T;T	195,5;190,1,1;188	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4656	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2991	154.4	1	SNP	p	S87R	1	.	.	259	261	CGT	693	695	CGT	201;194;194	C,A;G,A,T;T	195,5;190,1,1;188	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4656	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2991	154.4	1	SNP	p	R87I	0	.	.	259	261	CGT	693	695	CGT	201;194;194	C,A;G,A,T;T	195,5;190,1,1;188	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4656	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2991	154.4	1	SNP	p	S88P	0	.	.	262	264	TCC	696	698	TCC	195;199;198	T;C;C	193;195;194	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3930	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2822	138.3	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1562	1564	GGC	197;195;194	G;G;C	196;194;191	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.002	penA.2.002	1	1	27	3774	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2347	159.0	1	SNP	p	A311V	0	.	.	931	933	GCA	1223	1225	GCA	193;192;193	G;C;A	188;188;188	penA.2.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3774	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2347	159.0	1	SNP	p	I312M	0	.	.	934	936	ATC	1226	1228	ATC	192;191;193	A;T;C	190;189;188	penA.2.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3774	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2347	159.0	1	SNP	p	V316T	0	.	.	946	948	GTG	1238	1240	GTG	198;198;197	G;T;G	196;193;196	penA.2.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3774	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2347	159.0	1	SNP	p	V316P	0	.	.	946	948	GTG	1238	1240	GTG	198;198;197	G;T;G	196;193;196	penA.2.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3774	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2347	159.0	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1742	1744	ACC	173;174;175	A;C;C	164;172;172	penA.2.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3774	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2347	159.0	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1796	1798	GCG	183;178;175	G,C;C,G;G	171,1;158,4;164	penA.2.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3774	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2347	159.0	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1796	1798	GCG	183;178;175	G,C;C,G;G	171,1;158,4;164	penA.2.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3774	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2347	159.0	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1919	1921	GGC	131;132;129	G;G,T;C,T	130;130,1;125,4	penA.2.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3774	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2347	159.0	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1928	1930	GGC	126;124;123	G,A;G;C	117,4;122;122	penA.2.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3774	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2347	159.0	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1946	1948	CCG	107;108;107	C;C;G,C	100;104;91,1	penA.2.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5366	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3118	170.8	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1631	1633	CCG	143;145;148	C;C,T;G	136;143,1;142	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2182	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1867	115.8	0	.	p	.	0	M83fs	FSHIFT	247	247	A	602	602	C	132	C,G	125,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2780	porB1b	1035	1035	98.57	porB1b.l15.c17.ctg.1	1601	171.9	0	.	p	.	0	E48G	NONSYN	142	144	GAA	552	554	GGA	221;222;224	G;G,A;A	216;214,2;219	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2780	porB1b	1035	1035	98.57	porB1b.l15.c17.ctg.1	1601	171.9	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	1041	1041	T	191	T,C	180,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2780	porB1b	1035	1035	98.57	porB1b.l15.c17.ctg.1	1601	171.9	1	SNP	p	G120K	0	.	.	358	360	GGT	768	770	GGT	231;225;223	G;G;T	225;222;208	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2780	porB1b	1035	1035	98.57	porB1b.l15.c17.ctg.1	1601	171.9	1	SNP	p	A121N	0	.	.	361	363	GCC	771	773	GCC	221;217;218	G;C;C	217;212;216	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2780	porB1b	1035	1035	98.57	porB1b.l15.c17.ctg.1	1601	171.9	1	SNP	p	A121D	0	.	.	361	363	GCC	771	773	GCC	221;217;218	G;C;C	217;212;216	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9544	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4968	191.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1100	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	1152	94.3	1	SNP	p	V57M	1	.	.	169	171	ATG	662	664	ATG	196;194;197	A;T;G	193;189;193	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
